CRP and COVID-19: HRV has previously been used in patients with acute COVID-19 as a noninvasive measure of autonomic function, finding that, after an early increase in parasympathetic activity, patients with elevations of poor prognostic biomarkers, such as CRP (C-reactive protein), exhibited a prior loss of HRV [34,35].